These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3281901)

  • 1. Clearance of Serratia marcescens from blood in mice: role of hydrophobic versus mannose-sensitive interactions.
    Rumelt S; Metzger Z; Kariv N; Rosenberg M
    Infect Immun; 1988 May; 56(5):1167-70. PubMed ID: 3281901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface hydrophobicity of pigmented and nonpigmented clinical Serratia marcescens strains.
    Rosenberg M; Blumberger Y; Judes H; Bar-Ness R; Rubinstein E; Mazor Y
    Infect Immun; 1986 Mar; 51(3):932-5. PubMed ID: 3512440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.
    Traub WH; Kleber I
    Infect Immun; 1976 May; 13(5):1343-6. PubMed ID: 818023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of surface polysaccharide in determining the resistance of Serratia marcescens to serum killing.
    Jessop HL; Lambert PA
    J Gen Microbiol; 1986 Sep; 132(9):2505-14. PubMed ID: 3540205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of the commercial human IgG immunoglobulin preparation Polyglobin to enhance combined phagocytic and serum bactericidal activity of normal blood against Serratia marcescens.
    Traub WH
    Chemotherapy; 1983; 29(1):43-7. PubMed ID: 6339179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment with Concanavalin-A increases resistance of mice to peritoneal infection by Serratia marcescens.
    Arraes SM; Gaziri LC; Vidotto MC; Saridakis HO; Felipe I
    J Med Microbiol; 1997 Mar; 46(3):251-5. PubMed ID: 9126826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased cell surface hydrophobicity of a Serratia marcescens NS 38 mutant lacking wetting activity.
    Bar-Ness R; Avrahamy N; Matsuyama T; Rosenberg M
    J Bacteriol; 1988 Sep; 170(9):4361-4. PubMed ID: 3045093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of pigmented and nonpigmented mutants of Serratia marcescens with reduced cell surface hydrophobicity.
    Rosenberg M
    J Bacteriol; 1984 Oct; 160(1):480-2. PubMed ID: 6384200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple fimbrial haemagglutinins in Serratia species.
    Old DC; Adegbola R; Scott SS
    Med Microbiol Immunol; 1983; 172(2):107-15. PubMed ID: 6136898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of Serratia marcescens fimbriae with monoclonal antibodies.
    Jingushi S; Mitsuyama M; Moriya T; Amako K
    Infect Immun; 1987 Jul; 55(7):1600-6. PubMed ID: 2885276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serratia marcescens.
    Hejazi A; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):903-12. PubMed ID: 9368530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    Simberkoff MS; Ricupero I; Rahal JJ
    J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New fimbrial hemagglutinin in Serratia species.
    Adegbola RA; Old DC
    Infect Immun; 1982 Oct; 38(1):306-15. PubMed ID: 6128303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of nosocomial isolates of Serratia marcescens for NMRI mice: correlation with O-antigens O6 and O14.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):360-9. PubMed ID: 6182709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.